CYP2C19

CYP2C19 Gene Overview

What it Does:
The CYP2C19 gene produces an enzyme found primarily in the liver, where it plays a key role in:

• Hormone metabolism: Breaking down estradiol (E2) and supporting hormone balance.
• Detoxification: Clearing approximately 10% of commonly used medications, as well as toxins and metabolic byproducts.

Why This Matters to You:
Variants in the CYP2C19 gene affect how well your body metabolizes medications, hormones, and toxins. These differences can impact your response to medications, hormone-related conditions, and overall detoxification capacity.

Understanding the CYP2C19 Variants

Key Genotypes:

1. *2/*2: Poor metabolizer
2. *2/*17 or *1/*2: Intermediate metabolizer
3. *1/*17 or *17/*17: Ultra-rapid metabolizer (Protective)

Each genotype influences CYP2C19 enzyme activity and its role in detoxification and hormone metabolism.

1. Poor Metabolizer (*2/*2)

What It Means for You:
Carrying the *2/*2 genotype results in complete loss-of-function of the CYP2C19 enzyme.

• Detoxification & Hormone Balance:
• Reduced enzyme activity leads to:
• Build-up of toxins and metabolic byproducts.
• Potential accumulation or reduced efficiency of medications.
• Altered hormone metabolism may increase levels of estradiol (E2) and decrease production of anti-estrogenic metabolites, which may contribute to:
• Endometriosis.
• Breast cancer.

2. Intermediate Metabolizer (*2/*17 or *1/*2)

What It Means for You:
Carrying the *2/*17 or *1/*2 genotypes results in reduced CYP2C19 activity.

• Detoxification & Hormone Balance:
• Slower clearance of toxins, metabolic byproducts, and medications, which may:
• Lead to inefficiencies in medication metabolism.
• Increase the risk of estrogen dominance and related conditions, including:
• Endometriosis.
• Breast cancer.

3. Ultra-Rapid Metabolizer (*1/*17 or *17/*17)

What It Means for You:
Carrying the *1/*17 or *17/*17 genotypes results in enhanced CYP2C19 enzyme activity, which is protective.

• Detoxification & Hormone Balance:
• Increased enzyme activity leads to:
• Faster clearance of medications, toxins, and metabolic byproducts.
• More efficient hormone metabolism, potentially lowering the risk of estrogen-related conditions like:
• Breast cancer.
• Endometriosis.
• Enhanced CYP2C19 activity may be especially beneficial for individuals predisposed to estrogen-related cancers.

What This Means for You

• If you carry the *2/*2 genotype (poor metabolizer):
• Work with a doctor to monitor hormone levels and detoxification pathways.
• Limit exposure to environmental toxins and endocrine disruptors (e.g., BPA in plastics, pesticides) to reduce strain on your detox pathways.
• Monitor medications carefully, as slower metabolism may affect dosing.
• If you carry the *2/*17 or *1/*2 genotypes (intermediate metabolizer):
• Support your body’s detoxification pathways by maintaining a diet rich in cruciferous vegetables (e.g., broccoli, kale) and antioxidants (e.g., berries, green tea).
• Discuss any medication adjustments with your doctor to account for slower clearance.
• If you carry the *1/*17 or *17/*17 genotypes (ultra-rapid metabolizer):
• Enjoy the protective benefits of enhanced detoxification and hormone metabolism.
• Monitor medication efficacy, as faster metabolism may reduce the therapeutic effects of some drugs.
• Continue supporting overall health with a nutrient-dense diet and regular checkups to monitor hormone levels.

Next Step:
Speak with a genomics specialist or doctor to explore how your CYP2C19 gene affects your detoxification pathways, hormone balance, and medication metabolism, and create a plan to optimize your health.